Abstract
Covid-19 is now a 6.0 months old disease. After its first identification and early encounter, many speculations about its natural course and various pathogenesis mechanisms have been made. From ACE-II Rs mediated viral attachment to pneumocyte damage, and diffuse endotheliitis, still a lot is left to answer on pathogenesis, immunity and other important aspects of this disease. What we have now is some studies, observational lab and clinical data only that keeps us guessing what is going on with this novel disease.
Highlights
Covid-19 is a 6.0 months old disease
From ACE-II Rs mediated viral attachment to pneumocyte damage, and diffuse endotheliitis, still a lot is left to answer on pathogenesis, immunity and other important aspects of this disease [1,2,3]
Covid-19 has a capacity to overwhelm any of the finest health care systems in world, and citing these reasons it is rather too early for us to provide guidance or produce a position statement which is based on old observations or mere little data of itself, rather societies should have taken the task of pushing for more and more research and allowing clinician on the front to take their own decisions for treatment part with rapid update of available data
Summary
Covid-19 is a 6.0 months old disease. After its first identification and early encounter, many speculations about its natural course and various pathogenesis mechanisms have been made. *Corresponding author: Yash Javeri, CII Medical Task Force Member Head CCM and Emergency Medicine Regency Super Specialty Hospital – Lucknow, India VP Elect Society of neurocritical Care Past Chairman-SCCM Delhi NCR Convener – Indian Sepsis Forum.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
